Related Experiment Video
Updated: Aug 9, 2026

Principles of Rodent Surgery for the New Surgeon
Published on: January 6, 2011
First do no harm: routine use of aminoglycosides in the operating room
L May1, V B Navarro, J D Gottsch
1Johns Hopkins Hospital, Baltimore, Md., USA.
Abstract:
For decades aminoglycosides have been used routinely in intraocular surgery to prevent and treat endophthalmitis. However, as more and more studies are conducted, the reality is that these drugs are causing more harm than they are preventing. Summarized herein are the most recent studies concluding that even low-dose aminoglycosides can cause toxic retinal damage. The conclusion, with pertinent recommendations from the Johns Hopkins Hospital, Wilmer Eye Institute Infection Control Committee, is that the questionable benefit of use of aminoglycosides intraoperatively is not justified by the risk of injury.
Insights
Aminoglycosides, commonly used in eye surgery, pose a significant risk of toxic retinal damage, even at low doses. Recent studies suggest their intraoperative use is not justified by the potential benefits, outweighing the risk of injury.
Area of Science:
- Ophthalmology
- Retinal Toxicology
- Surgical Infection Prophylaxis
Background:
- Aminoglycosides have been standard for preventing and treating endophthalmitis in intraocular surgery for many years.
- Emerging evidence questions the safety and efficacy of their routine use.
Purpose of the Study:
- To review recent studies on the toxic effects of aminoglycosides on the retina.
- To evaluate the risk-benefit ratio of intraoperative aminoglycoside use in ophthalmic procedures.
Main Methods:
- Systematic review of recent scientific literature.
- Analysis of studies investigating aminoglycoside-induced retinal toxicity.
- Evaluation of clinical recommendations regarding aminoglycoside usage.
Main Results:
- Recent studies indicate that even low doses of aminoglycosides can lead to toxic retinal damage.
- The prophylactic or therapeutic benefits may be outweighed by the risk of ocular injury.
Conclusions:
- The routine intraoperative use of aminoglycosides in ophthalmic surgery is not recommended due to significant risks of retinal toxicity.
- Recommendations from institutions like Johns Hopkins Hospital, Wilmer Eye Institute support limiting or discontinuing their use.
More Related Videos
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
05:25Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
Published on: October 24, 2025
Related Concept Videos
Hand hygiene
Hand washing...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Skeletal Muscle Relaxants: Therapeutic Uses
Heart Failure Drugs: Inotropic Agents
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Aneurysm IV: Nursing Management